Cargando…

Current insights into severe sepsis in cancer patients

Detalles Bibliográficos
Autores principales:	Staudinger, Thomas, Pène, Frédéric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Medicina intensiva 2014
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304459/ https://www.ncbi.nlm.nih.gov/pubmed/25607260 http://dx.doi.org/10.5935/0103-507X.20140051

Ejemplares similares

Drotrecogin alfa (activated): does current evidence support treatment for any patients with severe sepsis?
por: Friedrich, Jan O, et al.
Publicado: (2006)

Sex and severe sepsis
por: Guidet, Bertrand, et al.
Publicado: (2013)

Is cytomegalovirus reactivation increasing the mortality of patients with severe sepsis?
por: Kalil, Andre C, et al.
Publicado: (2011)

The International Sepsis Forum's frontiers in sepsis: high cardiac output should be maintained in severe sepsis
por: Vincent, Jean-Louis
Publicado: (2003)

The International Sepsis Forum's frontiers in sepsis: high cardiac output should not be maintained in severe sepsis
por: Sharma, Vinay K, et al.
Publicado: (2003)

Antithrombin and hypercoagulability in sepsis: insights from thrombelastography?
por: Hoffmann, Johannes N, et al.
Publicado: (2007)

Unrevealing culture-negative severe sepsis
por: de Prost, Nicolas, et al.
Publicado: (2013)

Immunity, inflammation and sepsis: new insights and persistent questions
por: Frazier, W Joshua
Publicado: (2011)

Severe sepsis epidemiology: sampling, selection, and society
por: Linde-Zwirble, Walter T, et al.
Publicado: (2004)

The outcome of patients presenting to the emergency department with severe sepsis or septic shock
por: Rivers, Emanuel
Publicado: (2006)

Genomic Insights Into Sepsis Course Using Whole Exome Sequencing
por: Flores, Carlos, et al.
Publicado: (2016)

Anticoagulant properties of drotrecogin alfa (activated) during hemofiltration in patients with severe sepsis
por: de Pont, Anne CJM, et al.
Publicado: (2009)

Sparing brain damage in severe sepsis: a beginning
por: Young, G Bryan
Publicado: (2010)

The severity of sepsis: yet another factor influencing glycemic control
por: Krinsley, James S
Publicado: (2008)

Matrix metalloproteinases and their inhibitors: promising novel biomarkers in severe sepsis?
por: Hoffmann, Ursula, et al.
Publicado: (2009)

Collagen-related biomarkers in severe sepsis: a big stretch?
por: Morrison, Gavin, et al.
Publicado: (2009)

A rapidly progressing lymphocyte exhaustion after severe sepsis
por: Monneret, Guillaume, et al.
Publicado: (2012)

Steroid responses in sepsis: some novel thinking that may provide new insight
por: Deutschman, Clifford S
Publicado: (2013)

Increased blood flow by insulin infusion targeting normoglycemia in patients with severe sepsis: friend or foe?
por: Berghe, Greet Van den
Publicado: (2010)

Should heparin-binding protein levels be routinely monitored in patients with severe sepsis and septic shock?
por: Holub, Michal, et al.
Publicado: (2012)

Systematic screening is essential for early diagnosis of severe sepsis and septic shock
por: Westphal, Glauco Adrieno, et al.
Publicado: (2015)

Immunostimulation using granulocyte- and granulocyte-macrophage colony stimulating factor in patients with severe sepsis and septic shock
por: Schefold, Joerg C
Publicado: (2011)

Activated protein C in severe acute pancreatitis without sepsis? Not just yet ...
por: Shankar-Hari, Manu, et al.
Publicado: (2010)

Immune status in sepsis: the bug, the site of infection and the severity can make the difference
por: Cavaillon, Jean-Marc, et al.
Publicado: (2010)

Cortisol replacement for severe sepsis and septic shock: what should I do?
por: Annane, Djillali
Publicado: (2002)

Appropriate antibiotic dosing in severe sepsis and acute renal failure: factors to consider
por: González de Molina, Francisco Javier, et al.
Publicado: (2011)

Predicting treatment failure in severe sepsis and septic shock: looking for the Holy Grail
por: Ruiz-Rodríguez, Juan Carlos, et al.
Publicado: (2013)

Purification methods: a way to treat severe acute inflammation related to sepsis?
por: Lukaszewicz, Anne Claire, et al.
Publicado: (2013)

The International Sepsis Forum's controversies in sepsis: how will sepsis be treated in 2051?
por: Marshall, John C
Publicado: (2002)

The International Sepsis Forum's controversies in sepsis: how will sepsis be treated in 2051?
por: Abraham, Edward
Publicado: (2002)

Should microcirculation monitoring be used to guide fluid resuscitation in severe sepsis and septic shock?
por: Ospina-Tascón, Gustavo A., et al.
Publicado: (2015)

Current insights into the relationship between the gut microbiome and Sjögren’s syndrome
por: van der Meulen, Taco A., et al.
Publicado: (2020)

Death to sepsis: targeting apoptosis pathways in sepsis
por: Wheeler, Derek S
Publicado: (2009)

Severe sepsis: are PROWESS and PROWESS-SHOCK trials comparable? A clinical and statistical heterogeneity analysis
por: Kalil, Andre C, et al.
Publicado: (2013)

Consideration of Severe Coronavirus Disease 2019 As Viral Sepsis and Potential Use of Immune Checkpoint Inhibitors
por: Odabasi, Zekaver, et al.
Publicado: (2020)

Fitting a square peg into a round hole: are the current Surviving Sepsis Campaign guidelines feasible for Africa?
por: Jacob, Shevin T, et al.
Publicado: (2011)

Fluid Resuscitation in Patients Presenting with Sepsis: Current Insights
por: Macdonald, Stephen
Publicado: (2022)

The challenge of sepsis
por: Levy, Mitchell M
Publicado: (2004)

The Surviving Sepsis Campaign sepsis change bundles and clinical practice
por: Dellinger, R Phillip, et al.
Publicado: (2005)

Hypocholesterolemia in sepsis and critically ill or injured patients
por: Wilson, Robert F, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_qjlsc6bu5t77u3abvjqnn1v6ai